FeesSafety
Pluang+

Graphite One starts 3-month DOE-backed project to recover rare earths from Alaska garnets.

Market News
10 Nov 2026, 14:00 WIB
PRNewsWire
View Source
Bullish
Graphite One starts 3-month DOE-backed project to recover rare earths from Alaska garnets.

Graphite One Inc. has launched a three-month research program with Ames National Laboratory, funded by the U.S. Department of Energy, to develop a sustainable process for extracting rare earth elements (REEs) from garnet material at its Graphite Creek deposit in Alaska. The project will focus on leaching, separating heavy and light rare earths, and creating a scalable process flowsheet. This effort aims to add value to the largest natural graphite deposit in the U.S. and support domestic supply chains for critical materials used in technology and defense. The research will include mineral characterization, acid leaching optimization, and product purification, with results expected to guide future development and potential economic extraction of REEs.

Graphite One's research program on rare earth recoveries offers context for readers. For those tracking Basic Materials stocks, 26 out of 83 US-listed stocks rose while 54 fell. Notable movers include AG at USD 15.45 (-2.65%), CDE at USD 16.02 (-2.61%), and IAG at USD 19.34 (-2.52%) with 100% buy orders on Pluang, as of Nov 10, 2026 18:41 WIB.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
56 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
56 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
56 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
56 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App